Piasclédine 300mg box of 90 capsules

Symptomatic treatment ofosteoarthritis.

Arthrum H viscoelastic devices are recommended to maintain the endo-articular space, reduce pain and restore joint mobility by replacing and supplementing the elastoviscosity of the pathological synovial fluid in osteoarthritic joints.

OSTENIL® Tendon is a medical device indicated for the treatment of pain and limitation of mobility in the case of tendon disorders.

Indications: Piascledine® 300 is a drug indicated for symptomatic treatment (pain and functional discomfort) with delayed effect of osteoarthritis of the hip and knee

Indicated for the symptomatic treatment of osteoarthritis, particularly of the hip and knee. Chondrosulf contains chondroitin sulfate and is indicated for adults (over 15).

Chondrosulf is available in several dosages:

Chondrolsulf 400 mg box 84 capsules

Chondrolsulf 800 mg box 30 capsules

Chondrolsulf 800 mg box 90 capsules

Chondrolsulf 1200 mg box 30 doses

With its flagship active ingredients (CBD, Turmeric, Harpagophytum, Magnesium) Forté Flex Kiné CBD cream helps relieve and soothe muscle and joint pain.

Delayed-effect symptomatic treatment of osteoarthritis of the hip and knee.

1200 mg oral gel: Sachets, box of 30.

Chondrosulf is available in several dosages:

Chondrolsulf 400 mg box 84 capsules

Chondrolsulf 800 mg box 30 capsules

Chondrolsulf 800 mg box 90 capsules

Chondrolsulf 1200 mg box 30 doses

Description : This medication is recommended for painful osteoarthritis of the knee, with effusion.

Sinovial® HL is indicated for pain or reduced mobility due to degenerative diseases (osteoarthritis), post-traumatic diseases or tendinopathy linked to joint alterations.

SYNOVIUM HCS viscoelastic devices are indicated for the symptomatic treatment of gonarthrosis, in particular to reduce pain and restore joint mobility by replacing and supplementing the elasto-viscosity of the synovial fluid in arthritic joints.

The therapeutic indications are all types of painful gonarthrosis:

- Primary gonarthrosis (Kelgreen radiological stages I, II and III)

- Gonarthrosis and associated general factors:

- Ineffectiveness of usual treatments.

- Intolerance and/or contraindication to NSAIDs and/or analgesics.

- Taking anticoagulants, poly-medication (hypertension, diabetes, obesity, cardiovascular and gastrointestinal problems).

- Contraindications related to the fitting of a prosthesis: young patients and various contraindications related to the patient's condition.

- Early gonarthrosis in young patients.

- Gonarthrosis secondary to trauma and the aftermath of articular fractures.

Description: HYALEXO EXPANSCIENCE is a hyaluronic acid-based medical device indicated for the relief of pain in patients suffering fromosteoarthritis or degenerative joint diseases resulting in an alteration of the functional properties of synovial fluid.

Indication: Indicated for the symptomatic treatment of osteoarthritis, particularly of the hip and knee. Chondrosulf contains chondroitin sulfate and is indicated for adults (over 15 years of age).

Chondrosulf is available in several dosages:

Chondrolsulf 400 mg box 84 capsules

Chondrolsulf 800 mg box 30 capsules

Chondrolsulf 800 mg box 90 capsules

Chondrolsulf 1200 mg box 30 doses

Indications :

Flect'Expert Patch Harpagophytum unties, softens and relieves immediately the joint and muscle tensions of everyday life by providing a warm effect.

Description : GCA2700 Gel combines 16 targeted active ingredients, including Harpagophytum extract, Helichrysum floral water and Gaultheria essential oil with a soothing and relaxing fragrance.

Indications: This drug is indicated in adults (over 15 years), in the symptomatic treatment of pain of tendino-ligamentary origin, and post-traumatic pain: sprains and bruises. This drug is indicated in adults in the treatment of painful flare-ups of osteoarthritis of the knee, after a first medical opinion.

Indications: Synvisc-One (a viscosupplement) is a simple intra-articular injection used to relieve pain and discomfort associated with osteoarthritis of the knee for up to six months.